Analysis of usefulness of serum TFF1, 2, 3 mesurement for gastric cancer screening

Analysis of usefulness of serum TFF1, 2, 3 mesurement for gastric cancer screening - Gastric cancer screening using serum TFF1, 2, 3

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000001799

Enrollment

20000

Registered

2009-04-01

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Who agreed to participate in the study among people who receive health check program in NTT east Japan Kanto Hospital

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

Measure	Time frame
Whether serum TFF1, 2, and 3 value can select people who should receive endoscopic examination for gastric cancer.	—

Secondary

Measure	Time frame
Whether serum TFF1, 2 and 3 are better screening marker for gastric cancer than pepsinogen method.	—

Countries

Japan

Contacts

Public ContactNobuyuki Matsuhashi

NTT east Japan Kanto Hospital Endoscopy division

nmatuha-tky@umin.ac.jp03-3448-6245

Outcome results